A report suggests Indian generic drug companies may not be affected by US President Donald Trump's order. The order aims to ...

US executive order aims to reduce prescription drug costs by matching prices with other developed countries, facing legal ...

The report noted that many specifics of the executive order remain unclear. Authorities have not disclosed which drugs, countries, or companies the MFN model will cover.